Estimation of relative biological effectiveness of (225)Ac compared to (177)Lu during [(225)Ac]Ac-PSMA and [(177)Lu]Lu-PSMA radiopharmaceutical therapy using TOPAS/TOPAS-nBio/MEDRAS

AIM: Over recent years, [(225)Ac]Ac-PSMA and [(177)Lu]Lu-PSMA radiopharmaceutical therapy have evolved as a promising treatment option for advanced prostate cancer. Especially for alpha particle emitter treatments, there is still a need for improving dosimetry, which requires accurate values of rela...

Descripción completa

Detalles Bibliográficos
Autores principales: Rumiantcev, Mikhail, Li, Wei Bo, Lindner, Simon, Liubchenko, Grigory, Resch, Sandra, Bartenstein, Peter, Ziegler, Sibylle I., Böning, Guido, Delker, Astrid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495309/
https://www.ncbi.nlm.nih.gov/pubmed/37695374
http://dx.doi.org/10.1186/s40658-023-00567-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495309/
https://www.ncbi.nlm.nih.gov/pubmed/37695374
http://dx.doi.org/10.1186/s40658-023-00567-2

Ejemplares similares